nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—SERPINC1—atherosclerosis	0.751	1	CbGaD
Fondaparinux sodium—Ardeparin—SERPINC1—atherosclerosis	0.00706	1	CrCbGaD
Fondaparinux sodium—F10—Extrinsic Pathway—F3—atherosclerosis	0.00678	0.0506	CbGpPWpGaD
Fondaparinux sodium—F10—Extrinsic Pathway—F7—atherosclerosis	0.00464	0.0347	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Common Pathway—F5—atherosclerosis	0.00408	0.0305	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Common Pathway—THBD—atherosclerosis	0.00366	0.0273	CbGpPWpGaD
Fondaparinux sodium—F10—Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus—F7—atherosclerosis	0.00319	0.0238	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—PLA2G2A—atherosclerosis	0.00304	0.0227	CbGpPWpGaD
Fondaparinux sodium—F10—Common Pathway—SERPINC1—atherosclerosis	0.0029	0.0217	CbGpPWpGaD
Fondaparinux sodium—F10—Removal of aminoterminal propeptides from gamma-carboxylated proteins—F7—atherosclerosis	0.0029	0.0217	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation of protein precursors—F7—atherosclerosis	0.0029	0.0217	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—VWF—atherosclerosis	0.00263	0.0197	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—F3—atherosclerosis	0.00247	0.0185	CbGpPWpGaD
Fondaparinux sodium—F10—Intrinsic Pathway—SERPINC1—atherosclerosis	0.00247	0.0185	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—F7—atherosclerosis	0.00247	0.0185	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—F5—atherosclerosis	0.00234	0.0175	CbGpPWpGaD
Fondaparinux sodium—F10—Common Pathway—F5—atherosclerosis	0.00231	0.0172	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—THBD—atherosclerosis	0.0021	0.0157	CbGpPWpGaD
Fondaparinux sodium—F10—Common Pathway—THBD—atherosclerosis	0.00207	0.0154	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—KNG1—atherosclerosis	0.00197	0.0147	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—F5—atherosclerosis	0.00196	0.0147	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—VWF—atherosclerosis	0.00178	0.0133	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—F7—atherosclerosis	0.00169	0.0127	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—SERPINC1—atherosclerosis	0.00167	0.0124	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F3—atherosclerosis	0.00166	0.0124	CbGpPWpGaD
Fondaparinux sodium—F10—Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus—F2—atherosclerosis	0.00161	0.012	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F5—atherosclerosis	0.00158	0.0118	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—APOA2—atherosclerosis	0.00158	0.0118	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—CLU—atherosclerosis	0.00151	0.0112	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Common Pathway—F2—atherosclerosis	0.00149	0.0111	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—VWF—atherosclerosis	0.00149	0.0111	CbGpPWpGaD
Fondaparinux sodium—F10—Intrinsic Pathway—VWF—atherosclerosis	0.00149	0.0111	CbGpPWpGaD
Fondaparinux sodium—F10—Removal of aminoterminal propeptides from gamma-carboxylated proteins—F2—atherosclerosis	0.00147	0.011	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation of protein precursors—F2—atherosclerosis	0.00147	0.011	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—F7—atherosclerosis	0.00142	0.0106	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—THBD—atherosclerosis	0.00142	0.0106	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—F3—atherosclerosis	0.0014	0.0104	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—KNG1—atherosclerosis	0.00133	0.0099	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—F5—atherosclerosis	0.00132	0.00989	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—F2—atherosclerosis	0.00127	0.00949	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—PLAT—atherosclerosis	0.00127	0.00945	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—F2—atherosclerosis	0.00125	0.00933	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—VWF—atherosclerosis	0.0012	0.00893	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—THBD—atherosclerosis	0.00119	0.00887	CbGpPWpGaD
Fondaparinux sodium—F10—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F7—atherosclerosis	0.00117	0.00874	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F7—atherosclerosis	0.00114	0.00852	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—SERPINC1—atherosclerosis	0.00112	0.00838	CbGpPWpGaD
Fondaparinux sodium—F10—Intrinsic Pathway—KNG1—atherosclerosis	0.00111	0.00829	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—PLG—atherosclerosis	0.00108	0.00803	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAT—atherosclerosis	0.00102	0.0076	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAT—atherosclerosis	0.00101	0.00757	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—VWF—atherosclerosis	0.001	0.00749	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—F7—atherosclerosis	0.000957	0.00715	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F3—atherosclerosis	0.000941	0.00703	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—KNG1—atherosclerosis	0.000893	0.00667	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F5—atherosclerosis	0.000892	0.00666	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—APOA2—atherosclerosis	0.000892	0.00666	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—KNG1—atherosclerosis	0.00089	0.00665	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAUR—atherosclerosis	0.000885	0.00661	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAUR—atherosclerosis	0.000882	0.00659	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLG—atherosclerosis	0.000865	0.00646	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ESAM—atherosclerosis	0.000857	0.0064	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—F2—atherosclerosis	0.000857	0.0064	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—CLU—atherosclerosis	0.000851	0.00635	CbGpPWpGaD
Fondaparinux sodium—F10—Common Pathway—F2—atherosclerosis	0.000843	0.00629	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—VCAM1—atherosclerosis	0.000842	0.00629	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—THBD—atherosclerosis	0.0008	0.00597	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—KNG1—atherosclerosis	0.000749	0.00559	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—CD40LG—atherosclerosis	0.000742	0.00554	CbGpPWpGaD
Fondaparinux sodium—F10—Intrinsic Pathway—F2—atherosclerosis	0.000718	0.00536	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—F2—atherosclerosis	0.000718	0.00536	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—VWF—atherosclerosis	0.000676	0.00505	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F7—atherosclerosis	0.000645	0.00481	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—VEGFA—atherosclerosis	0.000636	0.00475	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—liver—atherosclerosis	0.000602	0.531	CbGeAlD
Fondaparinux sodium—F10—Blood Clotting Cascade—SERPINE1—atherosclerosis	0.000597	0.00446	CbGpPWpGaD
Fondaparinux sodium—F10—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F2—atherosclerosis	0.000592	0.00442	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFB1—atherosclerosis	0.000584	0.00436	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F2—atherosclerosis	0.000577	0.00431	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAT—atherosclerosis	0.000575	0.00429	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—ICAM1—atherosclerosis	0.000573	0.00428	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—KNG1—atherosclerosis	0.000504	0.00377	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAUR—atherosclerosis	0.0005	0.00373	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLG—atherosclerosis	0.000489	0.00365	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ESAM—atherosclerosis	0.000484	0.00362	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—F2—atherosclerosis	0.000484	0.00361	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—SERPINE1—atherosclerosis	0.00048	0.00359	CbGpPWpGaD
Fondaparinux sodium—Urinary retention—Niacin—atherosclerosis	0.000456	0.00425	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—OLR1—atherosclerosis	0.00045	0.00336	CbGpPWpGaD
Fondaparinux sodium—Bronchitis—Simvastatin—atherosclerosis	0.000435	0.00405	CcSEcCtD
Fondaparinux sodium—Infestation—Ezetimibe—atherosclerosis	0.000422	0.00394	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Ezetimibe—atherosclerosis	0.000422	0.00394	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Lovastatin—atherosclerosis	0.000419	0.0039	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Niacin—atherosclerosis	0.000418	0.00389	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000417	0.00388	CcSEcCtD
Fondaparinux sodium—Dysphagia—Niacin—atherosclerosis	0.000415	0.00386	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Pravastatin—atherosclerosis	0.000411	0.00383	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Rosuvastatin—atherosclerosis	0.000408	0.0038	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.0004	0.00372	CcSEcCtD
Fondaparinux sodium—Bronchitis—Niacin—atherosclerosis	0.000399	0.00372	CcSEcCtD
Fondaparinux sodium—Sweating increased—Pravastatin—atherosclerosis	0.000398	0.00371	CcSEcCtD
Fondaparinux sodium—Flatulence—Rosuvastatin—atherosclerosis	0.000391	0.00365	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Ezetimibe—atherosclerosis	0.000374	0.00348	CcSEcCtD
Fondaparinux sodium—Angioedema—Rosuvastatin—atherosclerosis	0.000363	0.00338	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000359	0.00334	CcSEcCtD
Fondaparinux sodium—Flushing—Lovastatin—atherosclerosis	0.000359	0.00334	CcSEcCtD
Fondaparinux sodium—Myocardial infarction—Pravastatin—atherosclerosis	0.000357	0.00333	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Pravastatin—atherosclerosis	0.000354	0.0033	CcSEcCtD
Fondaparinux sodium—Flushing—Ezetimibe—atherosclerosis	0.000352	0.00328	CcSEcCtD
Fondaparinux sodium—Cough—Rosuvastatin—atherosclerosis	0.000347	0.00323	CcSEcCtD
Fondaparinux sodium—Angiopathy—Ezetimibe—atherosclerosis	0.000344	0.00321	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Ezetimibe—atherosclerosis	0.000343	0.00319	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000342	0.00318	CcSEcCtD
Fondaparinux sodium—Flushing—Simvastatin—atherosclerosis	0.000336	0.00313	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Niacin—atherosclerosis	0.000334	0.00311	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Niacin—atherosclerosis	0.000332	0.00309	CcSEcCtD
Fondaparinux sodium—Flatulence—Lovastatin—atherosclerosis	0.000332	0.00309	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Niacin—atherosclerosis	0.00033	0.00308	CcSEcCtD
Fondaparinux sodium—Malnutrition—Ezetimibe—atherosclerosis	0.00033	0.00308	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Lovastatin—atherosclerosis	0.00033	0.00307	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Niacin—atherosclerosis	0.000327	0.00305	CcSEcCtD
Fondaparinux sodium—Confusional state—Rosuvastatin—atherosclerosis	0.000327	0.00304	CcSEcCtD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F2—atherosclerosis	0.000326	0.00243	CbGpPWpGaD
Fondaparinux sodium—Back pain—Lovastatin—atherosclerosis	0.000326	0.00303	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Pravastatin—atherosclerosis	0.000325	0.00303	CcSEcCtD
Fondaparinux sodium—Flatulence—Ezetimibe—atherosclerosis	0.000325	0.00303	CcSEcCtD
Fondaparinux sodium—Infection—Rosuvastatin—atherosclerosis	0.000322	0.003	CcSEcCtD
Fondaparinux sodium—Back pain—Ezetimibe—atherosclerosis	0.000319	0.00297	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000318	0.00296	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000317	0.00296	CcSEcCtD
Fondaparinux sodium—Vision blurred—Lovastatin—atherosclerosis	0.000317	0.00295	CcSEcCtD
Fondaparinux sodium—Flatulence—Simvastatin—atherosclerosis	0.00031	0.00289	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Simvastatin—atherosclerosis	0.000308	0.00287	CcSEcCtD
Fondaparinux sodium—Flushing—Niacin—atherosclerosis	0.000308	0.00287	CcSEcCtD
Fondaparinux sodium—Angioedema—Lovastatin—atherosclerosis	0.000308	0.00286	CcSEcCtD
Fondaparinux sodium—Anaemia—Ezetimibe—atherosclerosis	0.000305	0.00284	CcSEcCtD
Fondaparinux sodium—Flushing—Pravastatin—atherosclerosis	0.000303	0.00283	CcSEcCtD
Fondaparinux sodium—Vertigo—Lovastatin—atherosclerosis	0.000302	0.00282	CcSEcCtD
Fondaparinux sodium—Angioedema—Ezetimibe—atherosclerosis	0.000302	0.00281	CcSEcCtD
Fondaparinux sodium—Angiopathy—Niacin—atherosclerosis	0.000301	0.00281	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—F3—atherosclerosis	0.000298	0.00223	CbGpPWpGaD
Fondaparinux sodium—Vision blurred—Simvastatin—atherosclerosis	0.000297	0.00276	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Niacin—atherosclerosis	0.000297	0.00276	CcSEcCtD
Fondaparinux sodium—Insomnia—Rosuvastatin—atherosclerosis	0.000293	0.00273	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Pravastatin—atherosclerosis	0.000292	0.00272	CcSEcCtD
Fondaparinux sodium—Palpitations—Ezetimibe—atherosclerosis	0.000292	0.00272	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Rosuvastatin—atherosclerosis	0.000291	0.00271	CcSEcCtD
Fondaparinux sodium—Anaemia—Simvastatin—atherosclerosis	0.000291	0.00271	CcSEcCtD
Fondaparinux sodium—Malnutrition—Niacin—atherosclerosis	0.000289	0.00269	CcSEcCtD
Fondaparinux sodium—Cough—Ezetimibe—atherosclerosis	0.000288	0.00268	CcSEcCtD
Fondaparinux sodium—Angioedema—Simvastatin—atherosclerosis	0.000288	0.00268	CcSEcCtD
Fondaparinux sodium—Chest pain—Lovastatin—atherosclerosis	0.000287	0.00267	CcSEcCtD
Fondaparinux sodium—Anxiety—Lovastatin—atherosclerosis	0.000286	0.00266	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Rosuvastatin—atherosclerosis	0.000285	0.00266	CcSEcCtD
Fondaparinux sodium—Flatulence—Niacin—atherosclerosis	0.000285	0.00265	CcSEcCtD
Fondaparinux sodium—Vertigo—Simvastatin—atherosclerosis	0.000283	0.00263	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—F5—atherosclerosis	0.000283	0.00211	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SELP—atherosclerosis	0.000283	0.00211	CbGpPWpGaD
Fondaparinux sodium—Chest pain—Ezetimibe—atherosclerosis	0.000281	0.00262	CcSEcCtD
Fondaparinux sodium—Flatulence—Pravastatin—atherosclerosis	0.00028	0.00261	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000279	0.0026	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Pravastatin—atherosclerosis	0.000279	0.0026	CcSEcCtD
Fondaparinux sodium—Pain—Rosuvastatin—atherosclerosis	0.000277	0.00258	CcSEcCtD
Fondaparinux sodium—Constipation—Rosuvastatin—atherosclerosis	0.000277	0.00258	CcSEcCtD
Fondaparinux sodium—Confusional state—Lovastatin—atherosclerosis	0.000277	0.00258	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Lovastatin—atherosclerosis	0.000275	0.00256	CcSEcCtD
Fondaparinux sodium—Infection—Lovastatin—atherosclerosis	0.000273	0.00254	CcSEcCtD
Fondaparinux sodium—Vision blurred—Niacin—atherosclerosis	0.000272	0.00254	CcSEcCtD
Fondaparinux sodium—Confusional state—Ezetimibe—atherosclerosis	0.000272	0.00253	CcSEcCtD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—SERPINE1—atherosclerosis	0.000271	0.00203	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CLU—atherosclerosis	0.00027	0.00202	CbGpPWpGaD
Fondaparinux sodium—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000269	0.00251	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Lovastatin—atherosclerosis	0.000269	0.00251	CcSEcCtD
Fondaparinux sodium—Vision blurred—Pravastatin—atherosclerosis	0.000268	0.0025	CcSEcCtD
Fondaparinux sodium—Chest pain—Simvastatin—atherosclerosis	0.000268	0.0025	CcSEcCtD
Fondaparinux sodium—Infection—Ezetimibe—atherosclerosis	0.000268	0.00249	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000267	0.00249	CcSEcCtD
Fondaparinux sodium—Anxiety—Simvastatin—atherosclerosis	0.000267	0.00249	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000265	0.00247	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Ezetimibe—atherosclerosis	0.000264	0.00246	CcSEcCtD
Fondaparinux sodium—Angioedema—Niacin—atherosclerosis	0.000264	0.00246	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000264	0.00246	CcSEcCtD
Fondaparinux sodium—Anaemia—Pravastatin—atherosclerosis	0.000263	0.00245	CcSEcCtD
Fondaparinux sodium—Anorexia—Lovastatin—atherosclerosis	0.000262	0.00244	CcSEcCtD
Fondaparinux sodium—Skin disorder—Ezetimibe—atherosclerosis	0.000262	0.00244	CcSEcCtD
Fondaparinux sodium—Angioedema—Pravastatin—atherosclerosis	0.00026	0.00242	CcSEcCtD
Fondaparinux sodium—Vertigo—Niacin—atherosclerosis	0.00026	0.00242	CcSEcCtD
Fondaparinux sodium—Syncope—Niacin—atherosclerosis	0.000259	0.00241	CcSEcCtD
Fondaparinux sodium—Confusional state—Simvastatin—atherosclerosis	0.000259	0.00241	CcSEcCtD
Fondaparinux sodium—Urticaria—Rosuvastatin—atherosclerosis	0.000257	0.0024	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Simvastatin—atherosclerosis	0.000257	0.00239	CcSEcCtD
Fondaparinux sodium—Oedema—Simvastatin—atherosclerosis	0.000257	0.00239	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Rosuvastatin—atherosclerosis	0.000256	0.00239	CcSEcCtD
Fondaparinux sodium—Vertigo—Pravastatin—atherosclerosis	0.000256	0.00238	CcSEcCtD
Fondaparinux sodium—Palpitations—Niacin—atherosclerosis	0.000255	0.00238	CcSEcCtD
Fondaparinux sodium—Infection—Simvastatin—atherosclerosis	0.000255	0.00238	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—OLR1—atherosclerosis	0.000254	0.0019	CbGpPWpGaD
Fondaparinux sodium—Loss of consciousness—Niacin—atherosclerosis	0.000254	0.00237	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—THBD—atherosclerosis	0.000254	0.00189	CbGpPWpGaD
Fondaparinux sodium—Cough—Niacin—atherosclerosis	0.000252	0.00235	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Simvastatin—atherosclerosis	0.000252	0.00234	CcSEcCtD
Fondaparinux sodium—Insomnia—Lovastatin—atherosclerosis	0.000248	0.00231	CcSEcCtD
Fondaparinux sodium—Cough—Pravastatin—atherosclerosis	0.000248	0.00231	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Lovastatin—atherosclerosis	0.000247	0.0023	CcSEcCtD
Fondaparinux sodium—Anorexia—Simvastatin—atherosclerosis	0.000245	0.00228	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Lovastatin—atherosclerosis	0.000245	0.00228	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000244	0.00228	CcSEcCtD
Fondaparinux sodium—Insomnia—Ezetimibe—atherosclerosis	0.000244	0.00227	CcSEcCtD
Fondaparinux sodium—Chest pain—Pravastatin—atherosclerosis	0.000242	0.00226	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Ezetimibe—atherosclerosis	0.000242	0.00225	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Lovastatin—atherosclerosis	0.000242	0.00225	CcSEcCtD
Fondaparinux sodium—Anxiety—Pravastatin—atherosclerosis	0.000241	0.00225	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—SELE—atherosclerosis	0.00024	0.0018	CbGpPWpGaD
Fondaparinux sodium—Dyspnoea—Ezetimibe—atherosclerosis	0.00024	0.00224	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000239	0.00222	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Lovastatin—atherosclerosis	0.000239	0.00222	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Ezetimibe—atherosclerosis	0.000237	0.00221	CcSEcCtD
Fondaparinux sodium—Fatigue—Lovastatin—atherosclerosis	0.000237	0.00221	CcSEcCtD
Fondaparinux sodium—Oedema—Niacin—atherosclerosis	0.000236	0.0022	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Niacin—atherosclerosis	0.000236	0.0022	CcSEcCtD
Fondaparinux sodium—Pain—Lovastatin—atherosclerosis	0.000235	0.00219	CcSEcCtD
Fondaparinux sodium—Constipation—Lovastatin—atherosclerosis	0.000235	0.00219	CcSEcCtD
Fondaparinux sodium—Confusional state—Pravastatin—atherosclerosis	0.000234	0.00218	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Ezetimibe—atherosclerosis	0.000234	0.00218	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000233	0.00217	CcSEcCtD
Fondaparinux sodium—Asthenia—Rosuvastatin—atherosclerosis	0.000233	0.00217	CcSEcCtD
Fondaparinux sodium—Insomnia—Simvastatin—atherosclerosis	0.000232	0.00216	CcSEcCtD
Fondaparinux sodium—Oedema—Pravastatin—atherosclerosis	0.000232	0.00216	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Pravastatin—atherosclerosis	0.000232	0.00216	CcSEcCtD
Fondaparinux sodium—Fatigue—Ezetimibe—atherosclerosis	0.000232	0.00216	CcSEcCtD
Fondaparinux sodium—Shock—Niacin—atherosclerosis	0.000232	0.00216	CcSEcCtD
Fondaparinux sodium—Infection—Pravastatin—atherosclerosis	0.000231	0.00215	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Simvastatin—atherosclerosis	0.000231	0.00215	CcSEcCtD
Fondaparinux sodium—Constipation—Ezetimibe—atherosclerosis	0.00023	0.00215	CcSEcCtD
Fondaparinux sodium—Pain—Ezetimibe—atherosclerosis	0.00023	0.00215	CcSEcCtD
Fondaparinux sodium—Tachycardia—Niacin—atherosclerosis	0.00023	0.00214	CcSEcCtD
Fondaparinux sodium—Pruritus—Rosuvastatin—atherosclerosis	0.000229	0.00214	CcSEcCtD
Fondaparinux sodium—Skin disorder—Niacin—atherosclerosis	0.000229	0.00213	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Simvastatin—atherosclerosis	0.000229	0.00213	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Niacin—atherosclerosis	0.000228	0.00212	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Pravastatin—atherosclerosis	0.000227	0.00212	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Lovastatin—atherosclerosis	0.000226	0.00211	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Simvastatin—atherosclerosis	0.000226	0.00211	CcSEcCtD
Fondaparinux sodium—Anorexia—Niacin—atherosclerosis	0.000225	0.00209	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000225	0.00209	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Pravastatin—atherosclerosis	0.000225	0.00209	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Simvastatin—atherosclerosis	0.000223	0.00208	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Ezetimibe—atherosclerosis	0.000222	0.00207	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000222	0.00207	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Rosuvastatin—atherosclerosis	0.000222	0.00207	CcSEcCtD
Fondaparinux sodium—Fatigue—Simvastatin—atherosclerosis	0.000222	0.00206	CcSEcCtD
Fondaparinux sodium—Anorexia—Pravastatin—atherosclerosis	0.000221	0.00206	CcSEcCtD
Fondaparinux sodium—Hypotension—Niacin—atherosclerosis	0.00022	0.00205	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00022	0.00205	CcSEcCtD
Fondaparinux sodium—Constipation—Simvastatin—atherosclerosis	0.00022	0.00205	CcSEcCtD
Fondaparinux sodium—Pain—Simvastatin—atherosclerosis	0.00022	0.00205	CcSEcCtD
Fondaparinux sodium—Urticaria—Lovastatin—atherosclerosis	0.000218	0.00203	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Lovastatin—atherosclerosis	0.000217	0.00202	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Lovastatin—atherosclerosis	0.000217	0.00202	CcSEcCtD
Fondaparinux sodium—Dizziness—Rosuvastatin—atherosclerosis	0.000214	0.002	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—VWF—atherosclerosis	0.000214	0.0016	CbGpPWpGaD
Fondaparinux sodium—Urticaria—Ezetimibe—atherosclerosis	0.000214	0.00199	CcSEcCtD
Fondaparinux sodium—Insomnia—Niacin—atherosclerosis	0.000213	0.00199	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Ezetimibe—atherosclerosis	0.000213	0.00198	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Ezetimibe—atherosclerosis	0.000213	0.00198	CcSEcCtD
Fondaparinux sodium—F10—cardiovascular system—atherosclerosis	0.000212	0.187	CbGeAlD
Fondaparinux sodium—Paraesthesia—Niacin—atherosclerosis	0.000212	0.00197	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Simvastatin—atherosclerosis	0.000212	0.00197	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Niacin—atherosclerosis	0.00021	0.00196	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00021	0.00196	CcSEcCtD
Fondaparinux sodium—Insomnia—Pravastatin—atherosclerosis	0.00021	0.00196	CcSEcCtD
Fondaparinux sodium—Somnolence—Niacin—atherosclerosis	0.00021	0.00195	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Pravastatin—atherosclerosis	0.000209	0.00194	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Niacin—atherosclerosis	0.000208	0.00193	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Pravastatin—atherosclerosis	0.000207	0.00193	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Niacin—atherosclerosis	0.000205	0.00191	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Pravastatin—atherosclerosis	0.000204	0.0019	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—F7—atherosclerosis	0.000204	0.00153	CbGpPWpGaD
Fondaparinux sodium—Rash—Rosuvastatin—atherosclerosis	0.000204	0.0019	CcSEcCtD
Fondaparinux sodium—Dermatitis—Rosuvastatin—atherosclerosis	0.000204	0.0019	CcSEcCtD
Fondaparinux sodium—Urticaria—Simvastatin—atherosclerosis	0.000204	0.0019	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Niacin—atherosclerosis	0.000204	0.0019	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Simvastatin—atherosclerosis	0.000203	0.00189	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Simvastatin—atherosclerosis	0.000203	0.00189	CcSEcCtD
Fondaparinux sodium—Headache—Rosuvastatin—atherosclerosis	0.000203	0.00189	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Lovastatin—atherosclerosis	0.000202	0.00189	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Pravastatin—atherosclerosis	0.000202	0.00188	CcSEcCtD
Fondaparinux sodium—Pain—Niacin—atherosclerosis	0.000202	0.00188	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—SERPINC1—atherosclerosis	0.000201	0.0015	CbGpPWpGaD
Fondaparinux sodium—Fatigue—Pravastatin—atherosclerosis	0.0002	0.00187	CcSEcCtD
Fondaparinux sodium—Pain—Pravastatin—atherosclerosis	0.000199	0.00185	CcSEcCtD
Fondaparinux sodium—Constipation—Pravastatin—atherosclerosis	0.000199	0.00185	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Ezetimibe—atherosclerosis	0.000199	0.00185	CcSEcCtD
Fondaparinux sodium—Asthenia—Lovastatin—atherosclerosis	0.000197	0.00184	CcSEcCtD
Fondaparinux sodium—Pruritus—Lovastatin—atherosclerosis	0.000194	0.00181	CcSEcCtD
Fondaparinux sodium—Asthenia—Ezetimibe—atherosclerosis	0.000193	0.0018	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Niacin—atherosclerosis	0.000193	0.0018	CcSEcCtD
Fondaparinux sodium—Nausea—Rosuvastatin—atherosclerosis	0.000193	0.00179	CcSEcCtD
Fondaparinux sodium—F10—Post-translational protein modification—F7—atherosclerosis	0.000192	0.00143	CbGpPWpGaD
Fondaparinux sodium—Feeling abnormal—Pravastatin—atherosclerosis	0.000191	0.00178	CcSEcCtD
Fondaparinux sodium—Pruritus—Ezetimibe—atherosclerosis	0.000191	0.00178	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00019	0.00177	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Simvastatin—atherosclerosis	0.000189	0.00176	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Lovastatin—atherosclerosis	0.000188	0.00175	CcSEcCtD
Fondaparinux sodium—Urticaria—Niacin—atherosclerosis	0.000187	0.00175	CcSEcCtD
Fondaparinux sodium—F10—adipose tissue—atherosclerosis	0.000187	0.165	CbGeAlD
Fondaparinux sodium—Body temperature increased—Niacin—atherosclerosis	0.000187	0.00174	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Niacin—atherosclerosis	0.000187	0.00174	CcSEcCtD
Fondaparinux sodium—Urticaria—Pravastatin—atherosclerosis	0.000185	0.00172	CcSEcCtD
Fondaparinux sodium—Asthenia—Simvastatin—atherosclerosis	0.000184	0.00172	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Ezetimibe—atherosclerosis	0.000184	0.00172	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Pravastatin—atherosclerosis	0.000184	0.00171	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Pravastatin—atherosclerosis	0.000184	0.00171	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAT—atherosclerosis	0.000182	0.00136	CbGpPWpGaD
Fondaparinux sodium—Pruritus—Simvastatin—atherosclerosis	0.000182	0.00169	CcSEcCtD
Fondaparinux sodium—Dizziness—Lovastatin—atherosclerosis	0.000182	0.00169	CcSEcCtD
Fondaparinux sodium—Dizziness—Ezetimibe—atherosclerosis	0.000178	0.00166	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Simvastatin—atherosclerosis	0.000176	0.00164	CcSEcCtD
Fondaparinux sodium—Vomiting—Lovastatin—atherosclerosis	0.000175	0.00163	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Niacin—atherosclerosis	0.000174	0.00162	CcSEcCtD
Fondaparinux sodium—Rash—Lovastatin—atherosclerosis	0.000173	0.00161	CcSEcCtD
Fondaparinux sodium—Dermatitis—Lovastatin—atherosclerosis	0.000173	0.00161	CcSEcCtD
Fondaparinux sodium—Headache—Lovastatin—atherosclerosis	0.000172	0.0016	CcSEcCtD
Fondaparinux sodium—Vomiting—Ezetimibe—atherosclerosis	0.000171	0.0016	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Pravastatin—atherosclerosis	0.000171	0.00159	CcSEcCtD
Fondaparinux sodium—Dizziness—Simvastatin—atherosclerosis	0.00017	0.00158	CcSEcCtD
Fondaparinux sodium—Rash—Ezetimibe—atherosclerosis	0.00017	0.00158	CcSEcCtD
Fondaparinux sodium—Dermatitis—Ezetimibe—atherosclerosis	0.00017	0.00158	CcSEcCtD
Fondaparinux sodium—Asthenia—Niacin—atherosclerosis	0.000169	0.00158	CcSEcCtD
Fondaparinux sodium—Headache—Ezetimibe—atherosclerosis	0.000169	0.00157	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—F3—atherosclerosis	0.000169	0.00126	CbGpPWpGaD
Fondaparinux sodium—Pruritus—Niacin—atherosclerosis	0.000167	0.00155	CcSEcCtD
Fondaparinux sodium—Asthenia—Pravastatin—atherosclerosis	0.000167	0.00155	CcSEcCtD
Fondaparinux sodium—Pruritus—Pravastatin—atherosclerosis	0.000164	0.00153	CcSEcCtD
Fondaparinux sodium—Vomiting—Simvastatin—atherosclerosis	0.000163	0.00152	CcSEcCtD
Fondaparinux sodium—Nausea—Lovastatin—atherosclerosis	0.000163	0.00152	CcSEcCtD
Fondaparinux sodium—Rash—Simvastatin—atherosclerosis	0.000162	0.00151	CcSEcCtD
Fondaparinux sodium—Dermatitis—Simvastatin—atherosclerosis	0.000162	0.00151	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Niacin—atherosclerosis	0.000161	0.0015	CcSEcCtD
Fondaparinux sodium—Headache—Simvastatin—atherosclerosis	0.000161	0.0015	CcSEcCtD
Fondaparinux sodium—Nausea—Ezetimibe—atherosclerosis	0.00016	0.00149	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—KNG1—atherosclerosis	0.00016	0.00119	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SELP—atherosclerosis	0.00016	0.00119	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—F5—atherosclerosis	0.00016	0.00119	CbGpPWpGaD
Fondaparinux sodium—Diarrhoea—Pravastatin—atherosclerosis	0.000159	0.00148	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAUR—atherosclerosis	0.000159	0.00118	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Niacin—atherosclerosis	0.000156	0.00145	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PLG—atherosclerosis	0.000155	0.00116	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Pravastatin—atherosclerosis	0.000154	0.00143	CcSEcCtD
Fondaparinux sodium—Nausea—Simvastatin—atherosclerosis	0.000153	0.00142	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—CLU—atherosclerosis	0.000152	0.00114	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Niacin—atherosclerosis	0.00015	0.0014	CcSEcCtD
Fondaparinux sodium—Rash—Niacin—atherosclerosis	0.000149	0.00139	CcSEcCtD
Fondaparinux sodium—Dermatitis—Niacin—atherosclerosis	0.000149	0.00138	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—SOD1—atherosclerosis	0.000149	0.00111	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—PLAUR—atherosclerosis	0.000149	0.00111	CbGpPWpGaD
Fondaparinux sodium—Headache—Niacin—atherosclerosis	0.000148	0.00138	CcSEcCtD
Fondaparinux sodium—Vomiting—Pravastatin—atherosclerosis	0.000148	0.00138	CcSEcCtD
Fondaparinux sodium—Rash—Pravastatin—atherosclerosis	0.000146	0.00136	CcSEcCtD
Fondaparinux sodium—Dermatitis—Pravastatin—atherosclerosis	0.000146	0.00136	CcSEcCtD
Fondaparinux sodium—Headache—Pravastatin—atherosclerosis	0.000146	0.00136	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—THBD—atherosclerosis	0.000143	0.00107	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IGF2—atherosclerosis	0.000141	0.00105	CbGpPWpGaD
Fondaparinux sodium—Nausea—Niacin—atherosclerosis	0.00014	0.00131	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—PLA2G7—atherosclerosis	0.000139	0.00104	CbGpPWpGaD
Fondaparinux sodium—Nausea—Pravastatin—atherosclerosis	0.000138	0.00129	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—APOB—atherosclerosis	0.000137	0.00102	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SELE—atherosclerosis	0.000136	0.00101	CbGpPWpGaD
Fondaparinux sodium—F10—liver—atherosclerosis	0.000131	0.116	CbGeAlD
Fondaparinux sodium—SERPINC1—Hemostasis—PRKCG—atherosclerosis	0.000127	0.00095	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CD36—atherosclerosis	0.000124	0.000928	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VWF—atherosclerosis	0.000121	0.000905	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—F7—atherosclerosis	0.000116	0.000863	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PDGFB—atherosclerosis	0.000115	0.000856	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MMP1—atherosclerosis	0.000113	0.000846	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—HSPD1—atherosclerosis	0.000113	0.000842	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CAV1—atherosclerosis	0.000109	0.000811	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—APOA1—atherosclerosis	0.000108	0.000809	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—F2—atherosclerosis	0.000103	0.000772	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLAT—atherosclerosis	0.000103	0.000769	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS2—atherosclerosis	0.000102	0.000763	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CG—atherosclerosis	9.89e-05	0.000739	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—F2—atherosclerosis	9.68e-05	0.000723	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—F7—atherosclerosis	9.09e-05	0.000679	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IGF1—atherosclerosis	9.06e-05	0.000677	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—KNG1—atherosclerosis	9.04e-05	0.000675	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLAUR—atherosclerosis	8.96e-05	0.000669	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLG—atherosclerosis	8.76e-05	0.000654	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SERPINE1—atherosclerosis	8.6e-05	0.000643	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ALB—atherosclerosis	8.59e-05	0.000641	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SOD1—atherosclerosis	8.39e-05	0.000627	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS3—atherosclerosis	8.21e-05	0.000613	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—GHRL—atherosclerosis	8.1e-05	0.000605	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IGF2—atherosclerosis	7.97e-05	0.000595	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ACE—atherosclerosis	7.85e-05	0.000586	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—APOB—atherosclerosis	7.74e-05	0.000578	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PRKCG—atherosclerosis	7.19e-05	0.000537	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PLAUR—atherosclerosis	7.05e-05	0.000526	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CD36—atherosclerosis	7.02e-05	0.000524	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PLG—atherosclerosis	6.89e-05	0.000514	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PDGFB—atherosclerosis	6.48e-05	0.000484	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MMP1—atherosclerosis	6.4e-05	0.000478	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGF2—atherosclerosis	6.27e-05	0.000468	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CAV1—atherosclerosis	6.14e-05	0.000458	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—APOA1—atherosclerosis	6.12e-05	0.000457	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFA—atherosclerosis	5.92e-05	0.000442	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—F2—atherosclerosis	5.84e-05	0.000436	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NOS2—atherosclerosis	5.77e-05	0.000431	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MAPK3—atherosclerosis	5.6e-05	0.000418	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CG—atherosclerosis	5.59e-05	0.000418	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TGFB1—atherosclerosis	5.43e-05	0.000406	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IGF1—atherosclerosis	5.12e-05	0.000382	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MMP1—atherosclerosis	5.04e-05	0.000376	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—AGT—atherosclerosis	4.97e-05	0.000371	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—LEP—atherosclerosis	4.87e-05	0.000364	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SERPINE1—atherosclerosis	4.86e-05	0.000363	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ALB—atherosclerosis	4.85e-05	0.000362	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NOS3—atherosclerosis	4.64e-05	0.000347	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—F2—atherosclerosis	4.6e-05	0.000343	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—INS—atherosclerosis	4.16e-05	0.000311	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CCL2—atherosclerosis	4.1e-05	0.000306	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGF1—atherosclerosis	4.03e-05	0.000301	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MMP2—atherosclerosis	3.9e-05	0.000291	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT1—atherosclerosis	3.78e-05	0.000282	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VEGFA—atherosclerosis	3.34e-05	0.00025	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CXCL8—atherosclerosis	3.24e-05	0.000242	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MAPK3—atherosclerosis	3.16e-05	0.000236	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TGFB1—atherosclerosis	3.07e-05	0.000229	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—AKT1—atherosclerosis	2.13e-05	0.000159	CbGpPWpGaD
